Manufacturing active pharmaceutical ingredients (APIs) is a complex undertaking that requires specialized process knowledge, advanced manufacturing capabilities, and…
Disulfide bond formation is a key step in the manufacture of cysteine‑containing peptides, yet established oxidation…
Oligonucleotides are emerging new therapeutic entities and reliable selective analytical methods to determine their purity and related impurities…
GLP-1 receptor agonists are transforming peptide manufacturing. For decades, peptide APIs were typically produced at kilogram scale for…
In the highly competitive pharmaceutical industry, time to market plays a pivotal role in determining the success of…
Developing a peptide or oligonucleotide therapy requires more than scientific innovation, it demands a robust chemistry, manufacturing, and…
Developing peptide and oligonucleotide APIs demands a precise balance of efficiency, quality and compliance. To meet the growing…
